Abbott Laboratories (NYSE: ABT) reported third quarter 2024 earnings results today. Total reported sales increased 4.9% year-over-year to $10.6 billion. Organic sales
Abbott Laboratories
-(ABT)
XNYS:ABT
Abbott Laboratories (ABT) Q2 2024 Earnings: Key financials and quarterly highlights
Abbott Laboratories (NYSE: ABT) reported second quarter 2024 earnings results today. Net sales increased 4% year-over-year to $10.4 billion. Net earnings decreased
Key highlights from Abbott Laboratories (ABT) Q1 2024 earnings results
Abbott Laboratories (NYSE: ABT) reported its first quarter 2024 earnings results today. Total sales increased 2.2% year-over-year to $10 billion. Organic sales growth
Infographic: Highlights of Abbott Laboratories’ (ABT) Q4 2023 earnings report
Abbott Laboratories (NYSE: ABT), a diversified healthcare services company, Wednesday reported its fourth quarter 2023 financial results. Net income, excluding special items, increased
Infographic: Key highlights from Abbott Laboratories’ (ABT) Q3 2023 earnings results
Abbott Laboratories (NYSE: ABT) reported third quarter 2023 earnings results today. Net sales decreased 2.6% year-over-year to $10.1 billion. On an organic basis,
Key highlights from Abbott Laboratories (ABT) Q2 2023 earnings results
Abbott Laboratories (NYSE: ABT) reported second quarter 2023 earnings results today. Net sales decreased 11.4% year-over-year to $10 billion. Organic sales growth, excluding
Abbott Laboratories (ABT) Q1 2023 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q1 2023 earnings call dated Apr. 19, 2023 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations, Licensing and Acquisitions
Infographic: Highlights of Abbott Laboratories’ Q1 2023 results
Healthcare company Abbott Laboratories (NYSE: ABT) announced financial results for the first quarter of 2023, reporting a decline in net sales and
Key factors to consider before investing in Abbott Laboratories (ABT)
Abbott Laboratories (NYSE: ABT) has contributed significantly to COVID care activities by providing test kits, and the healthcare conglomerate’s revenues benefitted from
Abbott Laboratories (ABT) Q4 2022 Earnings Call Transcript
Abbott Laboratories (NYSE:ABT) Q4 2022 Earnings Call dated Jan. 25, 2023. Corporate Participants: Scott Leinenweber -- Vice President of Investor Relations, Licensing, and Acquisition
Infographic: How Abbott Laboratories (ABT) performed in Q4 2022 financial results
Abbott Laboratories (NYSE: ABT) reported fourth quarter 2022 earnings results today. Net sales declined 12% year-over-year to $10.1 billion. Net earnings decreased
Abbott (ABT) Q3 2022 Earnings Call Transcript
Abbott (NYSE: ABT) Q3 2022 earnings call dated Oct. 19, 2022 Corporate Participants: Scott Leinenweber -- Vice President of Investor Relations, Licensing, and Acquisition
Key highlights from Abbott (ABT) Q3 2022 earnings results
Abbott (NYSE: ABT) reported third quarter 2022 earnings results today. Sales decreased 4.7% year-over-year to $10.4 billion. On an organic basis, sales
Abbott (ABT) Q2 2022 Earnings Call Transcript
Abbott (NYSE: ABT) Q2 2022 earnings call dated Jul. 20, 2022 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations, Licensing and Acquisitions Robert
Abbott Laboratories (ABT) Earnings: 2Q22 Key Numbers
Abbott Laboratories (NYSE: ABT) reported second quarter 2022 earnings results. Total sales increased 10.1% year-over-year to $11.3 billion. On an organic basis,
Abbott Laboratories (ABT) stock remains a compelling buy. Here’s why
Like most healthcare-related businesses, Abbott Laboratories (NYSE: ABT) has been operating near full capacity for quite some time, with its diagnostics segment
Abbott Laboratories (ABT) Q1 2022 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q1 2022 earnings call dated Apr. 20, 2022 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations Robert B. Ford -- Chairman
Abbott Laboratories (ABT) Q1 2022 Infographic: Key financials and quarterly highlights
Abbott (NYSE: ABT) today reported its first-quarter financial results for the period ended March 31, 2022. GAAP net earnings for the first
Abbott Laboratories (ABT) Q4 2021 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q4 2021 earnings call dated Jan. 26, 2022 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations, Licensing & Acquisitions
Abbott Laboratories (ABT) Q3 2021 Earnings: Key financials and quarterly highlights
Abbott (NYSE: ABT) today reported its third quarter financial results for the period ended September 30, 2021. GAAP net earnings for the
Abbott Laboratories (ABT) Q3 2021 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q3 2021 earnings call dated Oct. 20, 2021 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations, Licensing & Acquisitions